These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Matrix and reservoir-type multipurpose vaginal rings for controlled release of dapivirine and levonorgestrel. Boyd P; Fetherston SM; McCoy CF; Major I; Murphy DJ; Kumar S; Holt J; Brimer A; Blanda W; Devlin B; Malcolm RK Int J Pharm; 2016 Sep; 511(1):619-629. PubMed ID: 27473275 [TBL] [Abstract][Full Text] [Related]
8. A silicone elastomer vaginal ring for HIV prevention containing two microbicides with different mechanisms of action. Fetherston SM; Boyd P; McCoy CF; McBride MC; Edwards KL; Ampofo S; Malcolm RK Eur J Pharm Sci; 2013 Feb; 48(3):406-15. PubMed ID: 23266465 [TBL] [Abstract][Full Text] [Related]
9. Characterization of silicone elastomer vaginal rings containing HIV microbicide TMC120 by Raman spectroscopy. Bell SE; Dennis AC; Fido LA; Malcolm RK; Sirimuthu NM; Toner CF; Woolfson AD J Pharm Pharmacol; 2007 Feb; 59(2):203-7. PubMed ID: 17270074 [TBL] [Abstract][Full Text] [Related]
10. Development and pharmacokinetics of a combination vaginal ring for sustained release of dapivirine and the protein microbicide 5P12-RANTES. McBride JW; Malcolm RK; Dias N; Cameron D; Offord RE; Hartley O; Kett VL; Devlin B; Boyd P Int J Pharm; 2019 Jun; 564():207-213. PubMed ID: 30999049 [TBL] [Abstract][Full Text] [Related]
11. Drug stability and product performance characteristics of a dapivirine-releasing vaginal ring under simulated real-world conditions. Murphy DJ; McCoy CF; Boyd P; Derrick T; Spence P; Devlin B; Malcolm RK Int J Pharm; 2019 Jun; 565():351-357. PubMed ID: 31085254 [TBL] [Abstract][Full Text] [Related]
12. Pre-clinical development of a combination microbicide vaginal ring containing dapivirine and darunavir. Murphy DJ; Desjardins D; Dereuddre-Bosquet N; Brochard P; Perrot L; Pruvost A; Le Grand R; Lagatie O; Vanhooren L; Feyaerts M; van Roey J; Malcolm RK J Antimicrob Chemother; 2014 Sep; 69(9):2477-88. PubMed ID: 24862093 [TBL] [Abstract][Full Text] [Related]
13. A modified SILCS contraceptive diaphragm for long-term controlled release of the HIV microbicide dapivirine. Major I; Boyd P; Kilbourne-Brook M; Saxon G; Cohen J; Malcolm RK Contraception; 2013 Jul; 88(1):58-66. PubMed ID: 23177261 [TBL] [Abstract][Full Text] [Related]
14. Development of a multi-layered vaginal tablet containing dapivirine, levonorgestrel and acyclovir for use as a multipurpose prevention technology. McConville C; Major I; Devlin B; Brimer A Eur J Pharm Biopharm; 2016 Jul; 104():171-9. PubMed ID: 27163243 [TBL] [Abstract][Full Text] [Related]
15. A safety and pharmacokinetic trial assessing delivery of dapivirine from a vaginal ring in healthy women. Nel A; Haazen W; Nuttall J; Romano J; Rosenberg Z; van Niekerk N AIDS; 2014 Jun; 28(10):1479-87. PubMed ID: 24901365 [TBL] [Abstract][Full Text] [Related]
16. Two into one does go: Formulation development of a multipurpose combination vaginal ring releasing dapivirine and metronidazole for prevention of HIV infection and treatment of bacterial vaginosis. Zhao X; Boyd P; Bashi YD; Murphy DJ; McCoy CF; Coulter S; Laverty G; Malcolm RK Int J Pharm; 2023 Dec; 648():123572. PubMed ID: 37926178 [TBL] [Abstract][Full Text] [Related]
17. Physicochemical considerations in the formulation development of silicone elastomer vaginal rings releasing 5-nitroimidazole drugs for the treatment of bacterial vaginosis. Zhao X; Boyd P; Dallal Bashi YH; McCoy CF; Karl Malcolm R Int J Pharm; 2023 Sep; 644():123296. PubMed ID: 37553058 [TBL] [Abstract][Full Text] [Related]
18. Development of dapivirine vaginal ring for HIV prevention. Devlin B; Nuttall J; Wilder S; Woodsong C; Rosenberg Z Antiviral Res; 2013 Dec; 100 Suppl():S3-8. PubMed ID: 24188702 [TBL] [Abstract][Full Text] [Related]
19. Refining the in vitro release test method for a dapivirine-releasing vaginal ring to match in vivo performance. Murphy DJ; Lim D; Armstrong R; McCoy CF; Bashi YHD; Boyd P; Derrick T; Spence P; Devlin B; Malcolm RK Drug Deliv Transl Res; 2023 Aug; 13(8):2072-2082. PubMed ID: 34674162 [TBL] [Abstract][Full Text] [Related]
20. Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide. Woolfson AD; Malcolm RK; Morrow RJ; Toner CF; McCullagh SD Int J Pharm; 2006 Nov; 325(1-2):82-9. PubMed ID: 16884869 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]